Skip to main content
. 2014 Jan;99(1):94–102. doi: 10.3324/haematol.2013.090233

Figure 1.

Figure 1.

ETP-ALL patients express high MEF2C, LMO2 and LYL1 levels but not ERG or BAALC. The expression of (A) MEF2C (probe set 239966_at), (B) LMO1 (probe set 206718_at), (C) LMO2 (probe set 204249_s_at), (D) LYL1 (probe set 210044_s_at), (E) ERG (probe set 1563392_at), and (F) BAALC (probe set 222780_s_at) was based on VSN normalized microarray gene expression data for ETP-ALL (gray squares) and non-ETP-ALL cases (white squares). For the ETP-ALL subgroup, the ABD and non-ABD cases are indicated separately.